About Mitofam
Add Pedigree
Help
About Mitofam
Add Pedigree
Help
MT-TK
A8344G
A8344G-F1
A8344G-F4
A8344G-F9
A8344G-F10
A8344G-F19
A8344G-F21
A8344G-F23
A8344G-F27
A8344G-F28
A8344G-F29
A8344G-F33
A8344G-F34
A8344G-F35
A8344G-F36
A8344G-F37
A8344G-F39
A8344G-F38
A8344G-F41
A8344G-F42
A8344G-F43
A8344G-F44
A8344G-F45
A8344G-F46
A8344G-F47
A8344G-F48
A8344G-F49
A8344G-F51
A8344G-F53
A8344G-F54
A8344G-F55
A8344G-F56
A8344G-F57
A8344G-F59
A8344G-F60
A8344G-F66
A8344G-F72
A8344G-F85
A8344G-F86
A8344G-F90
A8344G-F92
A8344G-F95
A8344G-F96
A8344G-F99
A8344G-F101
A8344G-F114
A8344G-F115
A8344G-F116
A8344G-F117
A8344G-F118
A8344G-F119
A8344G-F120
A8344G-F121
A8344G-F122
A8344G-F123
A8344G-F126
A8344G-F127
A8344G-F128
A8344G-F134
A8344G-F142
A8296G
A8296G-F14
A8296G-F19
A8296G-F20
A8296G-F22
A8296G-F23
A8296G-F24
A8296G-F25
A8296G-F28
A8302T
A8315C
A8319G
A8326G
A8326G-F2
A8326G-F1
A8332G
A8332G-F1
A8339G
A8343G
A8343G-F3
A8343G-F2
A8344G
A8348G
A8348G-F1
C8305T
C8305T-F1
G8299A
G8304A
G8304A-F1
G8313A
G8328A
G8328A-F1
G8340A
G8340A-F4
G8342A
G8342A-F1
G8361A
G8361A-F1
G8363A
G8363A-F1
G8363A-F2
G8363A-F3
G8363A-F4
G8363A-F9
G8363A-F10
T8306C
T8316C
T8316C-F1
T8355C
T8356C
T8356C-F3
T8356C-F2
T8357C
T8357C-F2
T8357C-F1
T8362G
Edit by Mitofam Team
-
+
首页
A8348G
# **General Information** | **Position** | **8348** | **Variant** | **m.8348A\>G** | **Locus** | **MT\-TK** | **RNA** | **tRNA Lys** | | --- | --- | --- | --- | --- | --- | --- | --- | | **Homoplasmy** | \+ | **Heteroplasmy** | \+ | **mitoTIP** | 33\.80% | **Pathogenicity** | Reported | "Pathogenicity" status is derived from published literature or predictions from bioinformatics tools. Researchers and clinicians are cautioned that additional data and/or analysis may still be necessary to confirm the pathological significance of these variants. For more information, please see [Mitofam Info](https://mitofam.com/doc/385/). # **Pedigree Information** The **m.8348A\>G** variant in MT\-TK has been reported in 3 pedigrees. To date, 4 carriers have been reported. Homoplasmy was reported in 1/4 carriers (25%), and 4/4 carriers (100%) were affected. The main clinical manifestations among affected carriers included easy fatigability, hypertrophic cardiomyopathy progressing to dilated cardiomyopathy, mild concentric left ventricular hypertrophy, SNHL, congestive heart failure, cortical atrophy, enlargement of the fourth ventricle, lactic acidosis, and other features. | **No.** | **Position** | **Variant** | **Family ID** | **Nationality** | **Diseases** | **Unaffected Maternal Relatives** | **Affected Maternal Relatives** | **Publication Year** | **PMID/Ref** | **Note** | | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | | 1 | 8348 | m.8348A\>G | [A8348G\-F1](https://mitofam.com/doc/2190/) | Japan | Cardiomyopathy | 1 | 1 | 2001 | [11446509](https://pubmed.ncbi.nlm.nih.gov/11446509/) | / | | 2 | 8348 | m.8348A\>G | A8348G\-F2 | Japan | Mental retardation / lactic acidosis; no cardiomyopathy | 0 | 0 | 2006 | [16337222](https://pubmed.ncbi.nlm.nih.gov/16337222/) | Patient 39 | | 3 | 8348 | m.8348A\>G | A8348G\-F3 | Japan | Sensorineural hearing loss | 0 | 2 | 2010 | [20111055](https://pubmed.ncbi.nlm.nih.gov/20111055/) | Pedigree shows affected mother and younger sister, but only proband has reported target molecular evidence. | # **Carrier Information** | **No.** | **Position** | **Variant** | **Family ID** | **Carrier ID** | **Type (Fam/De novo/Uninf)** | **Gender (F/M)** | **Proband (Y/N)** | **Affected (Y/N)** | **Die/Alive(D/A)** | **Age** | **Blood Mutant Level** | **Muscle Mutant level** | **Urine Mutant level** | **Other Mutant level** | **Clinical Features** | **Note** | | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | | 1 | 8348 | m.8348A\>G | A8348G\-F1 | A8348G\-F1\-II2 | Fam | M | N | Y | A | ND | Hetero; load NR | / | / | / | Mild concentric left ventricular hypertrophy; no cardiac symptoms | Blood mutant ratio was reported as higher than the proband, but no numeric value was given. | | 2 | 8348 | m.8348A\>G | A8348G\-F1 | A8348G\-F1\-II1 | Fam | M | Y | Y | A | 46 | Hetero; load NR | / | / | Mutant dominant (Heart tissue) | Hypertrophic cardiomyopathy progressing to dilated cardiomyopathy; congestive heart failure; ventricular arrhythmias | m.8348A\>G detected in blood and heart tissue; no numeric load reported. | | 3 | 8348 | m.8348A\>G | A8348G\-F2 | A8348G\-F2\-P1 | Uninf | M | Y | Y | ND | 12 | / | 34% | / | / | Easy fatigability; mild mental retardation from age 9 months; lactic acidosis; cortical atrophy; ventricular dilatation; enlargement of the fourth ventricle | Patient 39; Table 1 lists onset 9 months and negative family history; no cardiomyopathy; muscle respiratory chain enzyme activities showed complex I/IV decrease. | | 4 | 8348 | m.8348A\>G | A8348G\-F3 | A8348G\-F3\-P1 | Fam | M | Y | Y | A | 6 | Homo | / | / | / | SNHL; onset age 3; no reported cardiac symptoms | Blood DNA screening; Figure 2 calls A8348G homoplasmic. Mother and sister have HL but no reported target mutation test. | For abbreviations and other usage instructions, please see [Mitofam Info](https://mitofam.com/doc/385/).
Haoying Chen
2026年6月30日 20:19
转发
收藏文档
上一篇
下一篇
手机扫码
复制链接
手机扫一扫转发分享
复制链接
分享
链接
类型
密码
更新密码
有效期
Markdown文件
Word文件
PDF文档
PDF文档(打印)